콜마바이오텍
2,125KRWMarket close of 10/29 (Thu)
Down -0.70%-15KRWMarket close of 10/29 (Thu)
- Open
- 2,140
- High
- 2,155
- Low
- 2,080
- Day range
- Day range low 2,080 high 2,155, open 2,140, close 2,125, previous close 2,140
- Volume
- 1×10K shares
- 31.35 million KRW 0.14× the 20-session average
Market close of 10/29 (Thu)
Where it sits in the 1-year range
22%22% of the way up from the lowest close in 1 year (252 sessions) · -41.1% from the high
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsnot verifiedThe last four quarters are incomplete, so not verified
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
The other 2 are within the usual range
- Daily move-0.70%usual range
- Trading value0.1×usual range
See the full check report
Filings in the last 2 years · 1
Material events are checked for the top 400 stocks only — this stock shows periodic reports only.
- 2026-08-14Half-year report (2026.06)
Same sector · 바이오 R&D
Down -1.23%· 9 of 64 stocks up, preferred shares excluded · trading value 195.6B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 알테오젠 | Close over the last 20 sessions -13.6% | Down -1.35% | 51.8B KRW |
| SK바이오팜 | Close over the last 20 sessions +4.6% | Up +3.46% | 16.0B KRW |
| 디앤디파마텍 | Close over the last 20 sessions -0.4% | Down -2.80% | 15.7B KRW |
| 올릭스 | Close over the last 20 sessions -5.9% | Down -0.82% | 14.9B KRW |
| 리가켐바이오 | Close over the last 20 sessions -19.8% | Down -3.32% | 14.5B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 17 days
- Next data 11/2 (Mon) after 08:50
Related news
Tables, financials, investor flows and filing history are in the Detailed view.
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 86% of trading value, about 93% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.